Skip to content

Evaluation of the effectiveness of neurofeedback on irritable bowel syndrome

The effectiveness of neurofeedback on the severity of gastrointestinal symptoms, depression, anxiety, stress and quality of life in patients with irritable bowel syndrome (IBS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191215045743N1
Enrollment
45
Registered
2020-12-23
Start date
2020-11-10
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrom. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: Neurofeedback:For the intervention group, the neurofeedback method is performed from the unipolar protocol of anxiety at point PZ and for the treatment of depressio

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having diagnostic criteria for IBS based on Rome III criteria , all three types of IBS included: C, D and M kind age between 18 and 45 years education: at least second level at middle school degree

Exclusion criteria

Exclusion criteria: patients who refused to participate in study positive Family history of colon cancer WBC, parasites and blood in the stool History of thyroid disorders and abnormal thyroid test, Patients with unstable weight loss, anemia and eosinophilia, rectosigmoid and abnormal scoping Having diagnostic Criteria of Severe psychiatric and neurological disorders based on psychiatrist diagnosis. Having bloody stools

Design outcomes

Primary

MeasureTime frame
Severity of gastrointestinal symptoms of irritable bowel syndrome based on IBS Symptom Severity Questionnaire,Symptoms of depression, anxiety and stress based on the score in DASS-42,Quality of life based on score in IBS-QOL-34 questionnaire. Timepoint: Before the intervention, the severity of gastrointestinal symptoms, depression, anxiety, stress and quality of life are measured. The list of alpha and beta waves is saved after each session. At the end of the sessions, the rate of gastrointestinal symptoms, psychological symptoms and quality of life are measured. Method of measurement: IBS-SSS Intensity of Gastrointestinal Symptoms Questionnaire, DASS-42 Questionnaire - Quality of Life Assessment QOL-34. Record brain waves of alpha and beta waves.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmrollah Ebrahimi

Esfahan University of Medical Sciences

a_ebrahimi@med.mui.ac.ir+98 31 3668 9313

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026